Company intelligence / Profile preview
Zoe Biosciences
Los Angeles, California, United Stateszoebiosciences.com ↗
- Ownership
- Private
- Employees
- ~2
- Development stage
- Preclinical
01
Overview
The company is developing PAI-1 biologic inhibitors with high target selectivity and affinity, and has promising efficacy studies in mice with a murine antibody. They are also working on APJ small-molecule agonists.
- Therapeutic areas
- OtherEndocrinologyMetabolic Disorders
- Modalities
- Antibody therapeuticssmall molecules
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Sanford Burnham Prebys (licensing option for APJ agonists)
Beyond the preview
Go deeper on Zoe Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zoe Biosciences.